sk&f-38393 has been researched along with alprostadil in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kelly, E; Nahorski, SR | 1 |
| Convents, A; De Keyser, J; De Waele, M; Ebinger, G; Vauquelin, G | 1 |
2 other study(ies) available for sk&f-38393 and alprostadil
| Article | Year |
|---|---|
Specific inhibition of dopamine D-1-mediated cyclic AMP formation by dopamine D-2, muscarinic cholinergic, and opiate receptor stimulation in rat striatal slices.
Topics: 1-Methyl-3-isobutylxanthine; 2-Chloroadenosine; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adenosine; Alprostadil; Animals; Benzazepines; Carbachol; Cholera Toxin; Corpus Striatum; Cyclic AMP; Isoproterenol; Morphine; Phenethylamines; Rats; Receptors, Cholinergic; Receptors, Dopamine; Receptors, Muscarinic; Receptors, Opioid; Vasoactive Intestinal Peptide | 1986 |
Identification of D1-like dopamine receptors on human blood platelets.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adenylyl Cyclases; Alprostadil; Benzazepines; Binding, Competitive; Blood Platelets; Cell Membrane; Cyclic AMP; Dopamine; Dopamine Antagonists; Epinephrine; GTP-Binding Proteins; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Serotonin | 1988 |